Obesity Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment

Obesity Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Obesity is a multifactorial disorder, which is often associated with many other significant diseases such as diabetes, hypertension and other cardiovascular diseases, osteoarthritis, and certain cancers. The Obesity market is driven by the increasing prevalence of obesity, which has heightened the demand for new and effective drugs as current treatments often fall short of managing the condition. The expanding health and wellness sector, including fitness programs and dietary supplements, aligns with the increasing focus on weight management. Obesity is a multifactorial disorder, which is often associated with many other significant diseases such as diabetes, hypertension and other cardiovascular diseases, osteoarthritis, and certain cancers. The Obesity market is driven by the increasing prevalence of obesity, which has heightened the demand for new and effective drugs as current treatments often fall short of managing the condition. The expanding health and wellness sector, including fitness programs and dietary supplements, aligns with the increasing focus on weight management.

New York, USA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- DelveInsight’s report provides comprehensive global coverage of pipeline obesity therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the obesity pipeline domain. Request a sample and discover the recent advances in obesity treatment drugs @ The obesity pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage obesity drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an assessment of opportunities and risks in the obesity clinical trial landscape.

Obesity involves the excessive or abnormal accumulation of fat in the body, negatively impacting health and increasing the risk of diabetes mellitus, cardiovascular disease, hypertension, and hyperlipidemia. It has become a significant public health issue, worsening over the past 50 years. Obesity is a complex condition with multiple causes, including genetic, cultural, and societal factors, and is the second leading cause of preventable death after smoking.

Achieving a 5% to 10% weight loss can greatly enhance health, quality of life, and reduce economic burdens for individuals and countries. The imbalance between daily energy intake and expenditure leads to excessive weight gain, with reduced physical activity, poor diet, insomnia, endocrine disorders, and certain .